ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study.

E.F. Smit, K. Mattson, J. van Pawel, C Manegold, S Clarke, P.E. Postmus

Research output: Contribution to journal › Article › Academic › peer-review

Access to Document

@article{b8a3319dfdaa4b5c83464d3151f44e62,

title = "ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study.",

author = "E.F. Smit and K. Mattson and {van Pawel}, J. and C Manegold and S Clarke and P.E. Postmus",

year = "2003",

doi = "10.1093/annonc/mdg099",

language = "English",

volume = "14",

pages = "455--60",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study.

AU - Smit, E.F.

AU - Mattson, K.

AU - van Pawel, J.

AU - Manegold, C

AU - Clarke, S

AU - Postmus, P.E.

PY - 2003

Y1 - 2003

U2 - 10.1093/annonc/mdg099

DO - 10.1093/annonc/mdg099

M3 - Article

VL - 14

SP - 455

EP - 460

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 3

ER -